Cortado Ventures

Cortado Ventures, established in 2020 and headquartered in Oklahoma City, is an early-stage venture capital firm focused on investing in growth-driven startups across industries like fintech, biotech, aerospace, energy tech, and manufacturing. Their mission is to foster innovation in the Midcontinent region, supporting entrepreneurs who leverage technology to solve critical problems. Notable investments include PatchRx, which streamlines medication adherence, and Moat Biotechnology, a company developing life-saving intranasal vaccines. Cortado primarily invests in B2B companies, typically at the seed stage, and aims to accelerate their growth through hands-on support and strategic guidance. Co-founded by David Woods and Michael Moradi, the firm prides itself on providing rapid decision-making and a high degree of flexibility, which sets them apart from traditional venture capital models. Their focus on long-term relationships and nurturing local talent has positioned Cortado Ventures as a key player in the Midcontinent region’s entrepreneurial ecosystem.